Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
Masterson L, Howard J, Gonzalez-Cruz J, Jackson C, Barnett C, Overton L, Liu H, Ladwa R, Simpson F, McGrath M, Wallwork B, Jones T, Ottensmeier C, Chua MLK, Perry C, Khanna R, Panizza B, Porceddu S, Lechner M. Masterson L, et al. Among authors: mcgrath m. Int J Cancer. 2020 Apr 15;146(8):2305-2314. doi: 10.1002/ijc.32869. Epub 2020 Jan 28. Int J Cancer. 2020. PMID: 31950498 Review.
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).
Chandra J, Woo WP, Finlayson N, Liu HY, McGrath M, Ladwa R, Brauer M, Xu Y, Hanson S, Panizza B, Frazer IH, Porceddu SV. Chandra J, et al. Among authors: mcgrath m. Cancer Immunol Immunother. 2021 Mar;70(3):743-753. doi: 10.1007/s00262-020-02720-7. Epub 2020 Sep 12. Cancer Immunol Immunother. 2021. PMID: 32918586 Free PMC article. Clinical Trial.
Co-design and content validation of psychosis care assessment material for medical, pharmacy, nursing, and occupational therapy curricula.
Chen J, Collins JC, Scanlan JN, McCloughen A, Howard R, Ashton-James C, O'Reilly CL, Moles RJ, Ung TX, Schneider CR, Saini B, Ong J, Beckett P, Watson K, McGrath M, Chen TF, El-Den S. Chen J, et al. Among authors: mcgrath m. BMC Med Educ. 2025 Jan 8;25(1):34. doi: 10.1186/s12909-024-06580-y. BMC Med Educ. 2025. PMID: 39780138 Free PMC article.
A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F, McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J, Thomas D. Thavaneswaran S, et al. Among authors: mcgrath m. Oncologist. 2024 Dec 25:oyae339. doi: 10.1093/oncolo/oyae339. Online ahead of print. Oncologist. 2024. PMID: 39720993 Free article.
Editorial Comment.
Braga LH, McGrath M. Braga LH, et al. Among authors: mcgrath m. J Urol. 2024 Dec 24:101097JU0000000000004376. doi: 10.1097/JU.0000000000004376. Online ahead of print. J Urol. 2024. PMID: 39718383 No abstract available.
Elective outpatient middle meningeal artery embolization for chronic subdural hematoma is safe.
McGrath M, Gallagher A, Raub S, Carroll KT, Abecassis ZA, Ruiz Rodriguez JF, Philbrick BD, Kellner CP, Sioutas GS, Scott K, Srinivasan VM, Burkhardt JK, Shaikh HA, Khalife J, Tonetti DA, Lam N, Ares WJ, Gomez-Paz S, Budohoski K, Grandhi R, Levitt MR. McGrath M, et al. J Neurointerv Surg. 2024 Dec 18:jnis-2024-022568. doi: 10.1136/jnis-2024-022568. Online ahead of print. J Neurointerv Surg. 2024. PMID: 39694805
1,313 results